Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its product S-adenosyl-L-methionine 1,4-butanedisulfonate has recently completed the Self-GRAS (Self-affirmed Generally Recognized as Safe) scientific evaluation in accordance with US FDA GRAS guidelines and received unanimous approval from the expert panel, officially obtaining US Self-GRAS certification.
The company's S-adenosyl-L-methionine 1,4-butanedisulfonate receiving Self-GRAS certification means that this product has undergone scientific evaluation procedures and officially obtained market access qualification for the US market. It can now be sold and used as a safe dietary ingredient in the US market as well as other international markets that recognize US GRAS certification. This further enriches the company's profit structure and establishes a key foundation for the global expansion of the company's dietary supplement business.
Comments